About this trial
The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.
Eligibility criteria
Qualifiers
invited to screening
extremely dense breast (Study A) or a false positive screening result (Study B)
Disqualifiers
Opted out or not signed written consent related to the study
Women who have opted out from giving us permission to use screening data for quality assurance and research
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Norwegian Institute of Public Health
Lead sponsor
Norwegian Cancer Society
Collaborator
University Hospital, Akershus
Collaborator
Oslo University Hospital
Collaborator
Vestre Viken Hospital Trust
Collaborator